Proteinase K Market Size, Share, Growth Report 2030

Proteinase K Market

Proteinase K Market - By Form (Powder and Liquid), By Therapeutic Area (Neurology, Nephrology, Diabetes, Oncology, Contagious Diseases, Autoimmune Disease, and Cardiology), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026

Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-5465 Published Date: Jan-2021 Status : Published

The global Proteinase K Market, assessed at 6.08 (USD Billion) in 2019, is expected to earn 15.7 (USD Billion) by 2026, a CAGR of roughly 7.5%.

Proteinase K Market Size

The global Proteinase K Market, which was estimated at 6.08 (USD Billion) in 2019 and is anticipated to accrue earnings worth 15.7 (USD Billion) by 2026, is set to record a CAGR of nearly 7.5% over 2020-2026. The report offers valuation and analysis of the Proteinase K market on a global as well as regional level. The study offers a comprehensive assessment of the industry competition, limitations, sales estimates, avenues, current & emerging trends, and industry-validated market data. The report offers historical data from 2016 to 2019 along with a forecast from 2020 to 2026 based on value (USD Billion).

Global Proteinase K Market SizeRequest Free Sample

Proteinase K Market: Overview & Insights

Proteinase K is a broad-spectrum of serine protease and it was discovered in 1974 from fungus engyodontium extracts. Furthermore, the enzyme has the ability to digest hair protein referred to as keratin. The product is utilized in molecular biology for digesting protein and removing contamination occurring during preparing nucleic acids. The proteinase K enzyme is utilized for destroying proteins in cultured cells or cultured tissues and also facilitates nucleic acid release.

Furthermore, proteinase K also finds myriad use in purifying genomic DNA from bacteria. With the thriving Whole Genome Synthesis Market, the Proteinase K industry is likely to gain traction in the years ahead. The enzyme activity towards native proteins is promoted by EDTA, SDS, and Urea. Proteinase K remains active in myriad temperature ranges and is more effective in temperatures ranging from 20 degrees Celsius to 60 degrees Celsius.

Report Scope:

Report Attributes Report Details
Report Name Proteinase K Market Research Report
Market Size in 2019 6.08 (USD Billion)
Market Forecast in 2026 15.7 (USD Billion)
Compound Annual Growth Rate CAGR of 7.5%
Number of Pages 110
Forecast Units Value (USD Billion), and Volume (Units)
Key Companies Covered Advanced Enzymes Technologies Ltd., American Laboratories, Amicogen, Codexis, Inc., Affymetrix, BBI Solutions, Dyadic International, Amano Enzyme Inc., Biocatalysts Ltd., F. Hoffmann-La Roche Ltd., and Merck KGaA
Segments Covered By Type,By end-user, And By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA)
Countries Covered North America: U.S and Canada
Europe: Germany, Italy, Russia, U.K, Spain, France, Rest of Europe
APAC: China, Australia, Japan, India, South Korea, South East Asia, Rest of Asia Pacific
Latin America: Brazil, Argentina, Chile
The Middle East And Africa: South Africa, GCC, Rest of MEA
Base Year 2021
Historical Year 2016 to 2020
Forecast Year 2022 - 2030
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Proteinase K Market Growth Drivers

The expansion of the Proteinase K market over the assessment period is attributed to large-scale funding by research organizations, pharma, and bio-pharma firms for promoting product innovations. Large-scale use of the enzyme in nucleic acid & mitochondria isolation will leverage the growth of the proteinase k industry over the forecast timeframe.  Apparently, large-scale use of the enzyme in drug discovery, as well as diagnosis of disease, is predicted to favorably influence the proteinase K market size. Nonetheless, the presence of nucleases & other proteins in proteinase K can impede the growth of the business in the upcoming years.

Furthermore, escalating demand for recombinant genes facilitating the manufacture of monoclonal antibodies will prompt proteinase k industry size over the ensuing years. Apparently, bio-pharma and pharma firms are focusing on creating new biological products from the enzyme, thereby providing a boost to product penetration across the globe.

North America To Account Majorly For Overall Market Proceeds By 2026

The expansion of the Proteinase K market during the estimated timeframe is attributed to rise in the cancer cases in the nations like the U.S. Moreover, the occurrence of cancer has resulted in massive demand for next-generation sequencing techniques & PCR techniques that use proteinase K enzymes in the region, thereby steering the business trends in the sub-continent. Favorable schemes such as NSIGHT program introduced by National Human Genome Research Institute for screening infants for hereditary disorders have promoted the use of molecular biology procedure which involves proteinase K utilization. This, in turn, is expected to provide impetus to the regional industry growth over the forecast period.

Proteinase K Market: Competitive Players

Key participants profiled in the study are Advanced Enzymes Technologies Ltd., American Laboratories, Amicogen, Codexis, Inc., Affymetrix, BBI Solutions, Dyadic International, Amano Enzyme Inc., Biocatalysts Ltd., F. Hoffmann-La Roche Ltd., and Merck KGaA.

The global Proteinase K Market is segmented as follows:

By Form:

  • Powder
  • Liquid

By Therapeutic Area:

  • Neurology
  • Nephrology
  • Diabetes
  • Oncology
  • Contagious Diseases
  • Autoimmune Disease
  • Cardiology

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

Methodology

FrequentlyAsked Questions

The expansion of Proteinase K market over the assessment period is credited to humungous allocation of funds by research institutes, pharma companies, and bio-pharma firms for encouraging product developments. Large-scale use of the enzyme in nucleic acid & mitochondria isolation will favorably impact the growth of proteinase k market over the forecast timeframe.  Apart from this, large-scale use of the enzyme in drug discovery as well as diagnosis of disease is projected to lucratively influence the proteinase K market size.  

Furthermore, burgeoning demand for recombinant genes facilitating the manufacture of monoclonal anti-bodies will prompt proteinase k industry growth over the ensuing years. Apparently, bio-pharma and pharma firms are focusing on creating new biological products from the enzyme, thereby providing the boost to the product penetration across the globe.

According to Zion Market Research report, the global Proteinase K Market, which was estimated at 6.08 (USD Billion) in 2019 and is anticipated to accrue earnings worth 15.7 (USD Billion) by 2026, is set to record a CAGR of nearly 7.5% over 2020-2026.

North America is likely to make noteworthy contributions towards overall market revenue over the next couple of years. The growth of the market in the sub-continent over the estimated timeframe is credited to rise in the cancer cases in the nations like the U.S. Moreover, the high incidences of cancer has resulted in massive demand for next-generation sequencing technique & PCR technique that use proteinase K enzyme in the region, thereby steering the business trends in the sub-continent. Favorable schemes such as NSIGHT program introduced by National Human Genome Research Institute for screening infants for hereditary disorders have promoted the utility of molecular biology procedure that involves proteinase K utilization. This, in turn, is expected to provide impetus to the regional industry surge over the forecast timeline.

The key players profiled in the report include Advanced Enzymes Technologies Ltd., American Laboratories, Amicogen, Codexis, Inc., Affymetrix, BBI Solutions, Dyadic International, Amano Enzyme Inc., Biocatalysts Ltd., F. Hoffmann-La Roche Ltd., and Merck KGaA.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed